Menzen, Markus
14  Ergebnisse:
Personensuche X
?
 
?
3

Real-World Use of Once-Weekly Semaglutide in Type 2 Diabete..:

Menzen, Markus ; Berentzen, Tina Landsvig ; Catarig, Andrei-Mircea...
Experimental and Clinical Endocrinology & Diabetes.  131 (2023)  4 - p. 205-215 , 2023
 
?
4

Eine neue Welt: Verbesserung der Diabetestherapie durch dig..:

Menzen, Markus
DMW - Deutsche Medizinische Wochenschrift.  148 (2023)  6 - p. 288-293 , 2023
 
?
8

Pharmacological treatment options for mast cell activation ..:

Molderings, Gerhard J. ; Haenisch, Britta ; Brettner, Stefan...
Naunyn-Schmiedeberg's Archives of Pharmacology.  389 (2016)  7 - p. 671-694 , 2016
 
?
 
?
11

Dapagliflozin effects on haematocrit, red blood cell count ..:

Aberle, Jens ; Menzen, Markus ; Schmid, Sebastian M...
Aberle , J , Menzen , M , Schmid , S M , Terkamp , C , Jaeckel , E , Rohwedder , K , Scheerer , M F , Xu , J , Tang , W & Birkenfeld , A L 2020 , ' Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes ' , Scientific Reports , vol. 10 , no. 1 , 22396 . https://doi.org/10.1038/s41598-020-78734-z.  , 2020
 
?
12

Dapagliflozin effects on haematocrit, red blood cell count ..:

Aberle, Jens ; Menzen, Markus ; Schmid, Sebastian M...
Aberle , J , Menzen , M , Schmid , S M , Terkamp , C , Jaeckel , E , Rohwedder , K , Scheerer , M F , Xu , J , Tang , W & Birkenfeld , A L 2020 , ' Dapagliflozin effects on haematocrit, red blood cell count and reticulocytes in insulin-treated patients with type 2 diabetes ' , Scientific Reports , vol. 10 , no. 1 , 22396 . https://doi.org/10.1038/s41598-020-78734-z.  , 2020
 
1-14